This announcement is a separate document:
国泰君安证券股份有限公司关于长春百克生物科技股份公司2022年限制性股票激励计划首次授予部分第一个归属期归属条件成就事项之独立财务顾问报告
Independent Financial Advisory Report of Guotai Junan Securities Co., Ltd. on the achievements of Changchun Baike Biotech Co., Ltd. in the 2022 Restricted Stock Incentive Plan granted some of the first vesting period ownership conditions for the first time
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.